Ghent University Academic Bibliography

Mark

Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia

Elaine G Garcia, Sowmya Iyer, Sara P Garcia, Siebe Loontiens (UGent) , Ruslan I Sadreyev, Franki Speleman (UGent) and David M Langenau

(2018) LEUKEMIA. 32(8). p.1860-1865

Mark

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

C Piette, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, G Plat, N Dastugue, F Mazingue, et al.

(2018) LEUKEMIA. 32(1). p.244-248

Mark

journalArticle

The NF1 hotspot in acute myeloid leukemia: what’s in a name?

Karl Vandepoele (UGent) , Joni Van der Meulen (UGent) and Barbara Denys (UGent)

(2018) Leukemia.

Mark

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Sofie Peirs (UGent) , V Frismantas, Filip Matthijssens (UGent) , W Van Loocke, Tim Pieters (UGent) , Niels Vandamme (UGent) , Béatrice Lintermans (UGent) , MP Dobay, Geert Berx (UGent) , Bruce Poppe (UGent) , et al.

(2017) LEUKEMIA. 31(10). p.2037-2047

Mark

Leptin receptor antagonism of iNKT cell function : a novel strategy to combat multiple myeloma

Mérédis Favreau (UGent) , E Menu, Djoere Gaublomme (UGent) , K Vanderkerken, S Faict, K Maes, E De Bruyne, Srinath Govindarajan (UGent) , Michael Drennan (UGent) , Serge Van Calenbergh (UGent) , et al.

(2017) LEUKEMIA. 31(12). p.2678-2685

Mark

Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia

Annelynn Wallaert (UGent) , Kaat Durinck (UGent) , Wouter Van Loocke (UGent) , Inge Van de Walle (UGent) , Filip Matthijssens (UGent) , Pieter-Jan Volders (UGent) , Francisco Avila Cobos (UGent) , Dries Rombaut (UGent) , Pieter Rondou (UGent) , Pieter Mestdagh (UGent) , et al.

(2016) LEUKEMIA. 30(9). p.1927-1930

Mark

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951

E Clappier, N Grardel, M Bakkus, J Rapion, Barbara De Moerloose (UGent) , P Kastner, A Caye, J Vivent, V Costa, A Ferster, et al.

(2015) LEUKEMIA. 29(11). p.2154-2161

Mark

Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia

Kaat Durinck (UGent) , Wouter Van Loocke (UGent) , Joni Van der Meulen (UGent) , Inge Van de Walle (UGent) , Maté Ongenaert (UGent) , Pieter Rondou (UGent) , Annelynn Wallaert (UGent) , CE de Bock, Nadine Van Roy (UGent) , Bruce Poppe (UGent) , et al.

(2015) LEUKEMIA. 29(12). p.2317-2327

Mark

MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

Evelien Mets (UGent) , Joni Van der Meulen (UGent) , Gert Van Peer (UGent) , Michael Boice, Pieter Mestdagh (UGent) , Inge Van de Walle (UGent) , Tim Lammens (UGent) , Steven Goossens (UGent) , Barbara De Moerloose (UGent) , Yves Benoit (UGent) , et al.

(2015) LEUKEMIA. 29(4). p.798-806

Mark

misc

Magnesium and lymphoma: opportunities in translation

STEVEN VAN LAECKE, Evi Nagler (UGent) and Raymond Vanholder (UGent)

(2014) LEUKEMIA. 28(4). p.729-731

Academic Bibliography

Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

The NF1 hotspot in acute myeloid leukemia: what’s in a name?

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Leptin receptor antagonism of iNKT cell function : a novel strategy to combat multiple myeloma

Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951

Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia

MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

Magnesium and lymphoma: opportunities in translation

Contents

Support

Contact